Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Hirsutism in young girls can have various causes beyond PCOS, so diagnoses should be reconsidered if treatments don't work.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Insulin resistance varies among PCOS types, and simple math tools can help identify it early.

Young men with hair loss may have a higher risk of insulin resistance and related health issues.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

High BMI worsens hair growth in women with PCOS.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Male relatives of women with PCOS show similar health issues, suggesting a male version of the condition.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hair loss linked to higher heart disease risk in both men and women.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.